Skip to Main Content

Author Details

Niedzica Camacho
Memorial Sloan Kettering Cancer Center
2013
14
11
PMIDPaper TitleJournal TitlePublished Year
35110417Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors.Clin Cancer Res2022
32796921Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.Commun Biol2020
31725847Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.JAMA Oncol2020
33033409Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.Commun Biol2020
31237614Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.J Clin Endocrinol Metab2019
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
28777785Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.Nat Med2017
28481359Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.Nat Med2017
29045506Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.Ann Oncol2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
27020587KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.Ann Surg Oncol2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
23695019Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.Br J Cancer2013
  • 1 - 14 of 14

Recommended Authors

Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 2
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 3
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 13
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 11
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 11
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 2
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 16
Timothy Beck
Human Longevity Inc.
Career Start Year 2012
Number of shared co-authors 16
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 8
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 13
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 23
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2011
Number of shared co-authors 7
Kyung Park
New York University Langone Health
Career Start Year 2010
Number of shared co-authors 1
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 18
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 12
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 8
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 16
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 12
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 9
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 2
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 10
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 16
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 9
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 14
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 12
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 18
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 9
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 17

Collaborators

Michael F Berger
Co-authored papers 7
Hayley J Luxton
University College London
Co-authored papers 6
Hayley C Whitaker
University College London
Co-authored papers 6
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 5
Sue Merson
Institute of Cancer Research
Co-authored papers 5
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 5
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 5
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 4
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 4
Andy G Lynch
University of St Andrews
Co-authored papers 4
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Co-authored papers 4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 4
Lucy Matthews
University of Oxford
Co-authored papers 4
Erik Mayer
Imperial Clinical Analytics
Co-authored papers 4
David Nicol
The Royal Marsden Hospital
Co-authored papers 4
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 4
Adam Butler
Wellcome Sanger Institute
Co-authored papers 4
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 4
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers 4
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 4
Peter Van Loo
The Francis Crick Institute
Co-authored papers 4
Charlie E Massie
University of Cambridge
Co-authored papers 4
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 4
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 4
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 4
Nening Dennis
Institute of Cancer Research
Co-authored papers 4
David Jones
Wellcome Sanger Institute
Co-authored papers 4
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 4
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 4
Barbara Kremeyer
University College London
Co-authored papers 4
Release 1.2